Your browser doesn't support javascript.
loading
sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study.
Wimmer, Thomas; Mattes, Raphael; Stemmler, Hans-Joachim; Hauck, Fabian; Schulze-Koops, Hendrik; Stecher, Stephanie-Susanne; Starck, Michael; Wendtner, Clemens-Martin; Bojko, Peter; Hentrich, Marcus; Nickel, Katharina E; Götze, Katharina S; Bassermann, Florian; von Bergwelt-Baildon, Michael; Spiekermann, Karsten.
Afiliação
  • Wimmer T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Mattes R; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Stemmler HJ; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Hauck F; Division of Pediatric Immunology and Rheumatology, Department of Pediatrics at the Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany.
  • Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University Hospital, LMU Munich, Munich, Germany.
  • Stecher SS; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Starck M; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Munich Clinic Schwabing, Munich, Germany.
  • Wendtner CM; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Munich Clinic Schwabing, Munich, Germany.
  • Bojko P; Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany.
  • Hentrich M; Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany.
  • Nickel KE; Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Götze KS; Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Bassermann F; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • von Bergwelt-Baildon M; Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Spiekermann K; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Blood Adv ; 7(5): 832-844, 2023 03 14.
Article em En | MEDLINE | ID: mdl-35973195

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha